TipRanks
Go Ultimate55% OFF

Thomas Ricks Insider Profile

4 Followers

Thomas Ricks, Director at Ovintiv, holds 103.84K shares in Ovintiv (Ticker: OVV), holds 343.86K shares in Faeth Therapeutics (Ticker: FTH), holds 0.00 shares in Newfield (Ticker: ~NFX).

Thomas Ricks's Trading History

OVV
Ovintiv
May 26, 2026DirectorUninformative Buy206.63K$7.54M
FTH
Faeth Therapeutics
Jul 12, 2023DirectorUninformative Buy―$6.43M
~NFX
Newfield
Feb 14, 2019―Uninformative Sell―$0.00

You May Also Like

Thomas Ricks insider profile FAQ

What is the percentage of profitable transactions made by Thomas Ricks?
The percentage of profitable transactions made by Thomas Ricks is 57%.
What is the average return per transaction made by Thomas Ricks?
The average return per transaction made by Thomas Ricks is 236.80%.
What stocks does Thomas Ricks hold?
Thomas Ricks holds: OVV, ~NFX, FTH stocks.
What was Thomas Ricks’s latest transaction?
Thomas Ricks’s latest transaction was an Uninformative Buy of $206.63K.
What was Thomas Ricks's most profitable transaction?
Thomas Ricks’s most profitable transaction was an Informative Buy of OVV stock on March 10, 2020. The return on the trade was 800.00%.
What is Thomas Ricks's role in Ovintiv?
Thomas Ricks's role in Ovintiv is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.